Integra LifeSciences' (IART) "Market Outperform" Rating Reiterated at JMP Securities
Integra LifeSciences (NASDAQ:IART – Get Free Report)‘s stock had its “market outperform” rating reaffirmed by research analysts at JMP Securities in a report issued on Thursday, Benzinga reports. They presently have a $55.00 target price on the life sciences company’s stock. JMP Securities’ price objective would suggest a potential upside of 25.97% from the stock’s […]